Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Win, Yan Naung"'
Autor:
Chan, Xin Hui S, Win, Yan Naung, Mawer, Laura J, Tan, Jireh Y, Brugada, Josep, White, Nicholas J
Publikováno v:
In The Lancet Infectious Diseases August 2018 18(8):913-923
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chan, Xin Hui S.1,2 (AUTHOR) xinhui@tropmedres.ac, Win, Yan Naung1,3 (AUTHOR), Haeusler, Ilsa L.4,5 (AUTHOR), Tan, Jireh Y.1 (AUTHOR), Loganathan, Shanghavie1,6 (AUTHOR), Saralamba, Sompob1 (AUTHOR), Chan, Shu Kiat S.1,7 (AUTHOR), Ashley, Elizabeth A.2,8 (AUTHOR), Barnes, Karen I.9,10 (AUTHOR), Baiden, Rita11 (AUTHOR), Bassi, Peter U.12 (AUTHOR), Djimde, Abdoulaye13 (AUTHOR), Dorsey, Grant14 (AUTHOR), Duparc, Stephan15 (AUTHOR), Hanboonkunupakarn, Borimas1,16 (AUTHOR), ter Kuile, Feiko O.17 (AUTHOR), Lacerda, Marcus V. G.18,19 (AUTHOR), Nasa, Amit20 (AUTHOR), Nosten, François H.2,21 (AUTHOR), Onyeji, Cyprian O.22 (AUTHOR)
Publikováno v:
PLoS Medicine. 3/5/2020, Vol. 17 Issue 3, p1-20. 20p. 1 Diagram, 3 Charts, 3 Graphs.
Autor:
Chan, Xin Hui S., Chotsiri, Palang, Capel, Rebecca A., Pike, James, Hanboonkunupakarn, Borimas, Lee, Sue J., Hanafiah, Maryam, Win, Yan Naung, Cremer, Maegan A., Kiechel, Jean‐René, Ogutu, Bernhards, Taylor, Walter R. J., Burton, Rebecca‐Ann B., Tarning, Joel, White, Nicholas J.
Publikováno v:
British Journal of Clinical Pharmacology; Mar2023, Vol. 89 Issue 3, p1176-1186, 11p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Win, Yan Naung
Ramathibodi Medical Journal, 41, 2, 090-115
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4debef1c85259c01e0e8cfbcac2a15ea
Autor:
Chan, Xin Hui S, Win, Yan Naung, Haeusler, Ilsa L, Tan, Jireh Y, Loganathan, Shanghavie, Saralamba, Sompob, Chan, Shu Kiat S, Ashley, Elizabeth A, Barnes, Karen I, Baiden, Rita, Bassi, Peter U, Djimde, Abdoulaye, Dorsey, Grant, Duparc, Stephan, Hanboonkunupakarn, Borimas, Ter Kuile, Feiko O, Lacerda, Marcus VG, Nasa, Amit, Nosten, François H, Onyeji, Cyprian O, Pukrittayakamee, Sasithon, Siqueira, André M, Tarning, Joel, Taylor, Walter RJ, Valentini, Giovanni, Van Vugt, Michèle, Wesche, David, Day, Nicholas PJ, Huang, Christopher L-H, Brugada, Josep, Price, Ric N, White, Nicholas J
BACKGROUND: Electrocardiographic QT interval prolongation is the most widely used risk marker for ventricular arrhythmia potential and thus an important component of drug cardiotoxicity assessments. Several antimalarial medicines are associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbe376f454b20238f34ff17f8da5115d
Autor:
Chan, Xin Hui S., Win, Yan Naung, Haeusler, Ilsa L., Tan, Jireh Y., Loganathan, Shanghavie, Saralamba, Sompob, Chan, Shu Kiat S., Ashley, Elizabeth A., Barnes, Karen I., Baiden, Rita, Bassi, Peter U., Djimde, Abdoulaye, Dorsey, Grant, Duparc, Stephan, Hanboonkunupakarn, Borimas, Ter Kuile, Feiko O., Lacerda, Marcus V. G., Nasa, Amit, Nosten, François H., Onyeji, Cyprian O., Pukrittayakamee, Sasithon, Siqueira, André M., Tarning, Joel, Taylor, Walter R. J., Valentini, Giovanni, Van Vugt, Michèle, Wesche, David, Day, Nicholas P. J., Huang, Christopher L-H, Brugada, Josep, Price, Ric N., White, Nicholas J.
Background: Electrocardiographic QT interval prolongation is the most widely used risk marker for ventricular arrhythmia potential and thus an important component of drug cardiotoxicity assessments. Several antimalarial medicines are associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31ca65bca9554615ef5bf2c7b429f6bc
Autor:
Michèle van Vugt, Marcus V. G. Lacerda, PU Bassi, Amit Nasa, Rita Baiden, Feiko O. ter Kuile, Karen I. Barnes, Xin Hui S Chan, Stephan Duparc, Giovanni Valentini, Nicholas P. J. Day, Cyprian O. Onyeji, Yan Naung Win, Sasithon Pukrittayakamee, Shu Kiat S. Chan, Elizabeth A. Ashley, Nicholas J. White, Christopher L.-H. Huang, François Nosten, Walter R. J. Taylor, Josep Brugada, Joel Tarning, André Siqueira, Ilsa L. Haeusler, Sompob Saralamba, Borimas Hanboonkunupakarn, David Wesche, Grant Dorsey, Jireh Y. Tan, Ric N. Price, Abdoulaye Djimde, Shanghavie Loganathan
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 17, Iss 3, p e1003040 (2020)
PLoS medicine, 17(3). Public Library of Science
PLoS Medicine, Vol 17, Iss 3, p e1003040 (2020)
PLoS medicine, 17(3). Public Library of Science
Background Electrocardiographic QT interval prolongation is the most widely used risk marker for ventricular arrhythmia potential and thus an important component of drug cardiotoxicity assessments. Several antimalarial medicines are associated with Q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::769584c6e2b8c9d1327e1bdb58f4c8a3
https://www.repository.cam.ac.uk/handle/1810/303097
https://www.repository.cam.ac.uk/handle/1810/303097